The present invention is concerned with novel anthracyclines which are compounds of the general formula, ##STR1## wherein R.sub.1 is a methyl or acetonyl group and R.sub.2 is selected from the group consisting of ##STR2## Also presented is a method of making the above compounds. The compounds possess antibacterial and antitumor activities.